LOS ANGELES–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24CORT&src=ctag” target=”_blank”gt;$CORTlt;/agt; lt;a href=”https://twitter.com/hashtag/ClassAction?src=hash” target=”_blank”gt;#ClassActionlt;/agt;–The
Schall Law Firm, a national shareholder rights litigation firm,
announces that it is investigating claims on behalf of investors of
Corcept Therapeutics Incorporated (“Corcept” or “the Company”) (NASDAQ: CORT)
for violations of §§10(b) and 20(a) of the Securities Exchange Act of
1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and
Exchange Commission.
The investigation focuses on whether the Company issued false and/or
misleading statements and/or failed to disclose information pertinent to
investors. Corcept made improper payments to doctors to promote its
drug, Korlym. The Company also heavily promoted the drug for off-label
uses. Corcept’s single specialty pharmacy was a related party. The
Company inflated its sales and revenues using questionable sales
practices through a related party. Based on these facts, the Company’s
public statements were false and materially misleading throughout the
class period. When the market learned the truth about Corcept, investors
suffered damages.
If you are a shareholder who suffered a loss, click
here to participate.
We also encourage you to contact Brian Schall, or Sherin Mahdavian, of
the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA
90067, at 424-303-1964, to discuss your rights free of charge. You can
also reach us through the firm’s website at www.schallfirm.com,
or by email at [email protected].
The class in this case has not yet been certified, and until
certification occurs, you are not represented by an attorney. If you
choose to take no action, you can remain an absent class member.
The Schall Law Firm represents investors around the world and
specializes in securities class action lawsuits and shareholder rights
litigation.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and rules of ethics.
Contacts
The Schall Law Firm
Brian Schall, Esq.
Rina Restaino, Esq.
310-301-3335
Cell:
424-303-1964
[email protected]
www.schallfirm.com
